Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
KUR-502 by Athenex for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval
KUR-502 is under clinical development by Athenex and currently in Phase I for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic...
Data Insights
KUR-502 by Athenex for B-Cell Chronic Lymphocytic Leukemia: Likelihood of Approval
KUR-502 is under clinical development by Athenex and currently in Phase I for B-Cell Chronic Lymphocytic Leukemia. According to GlobalData,...